Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Clinical and Experimental Hepatology
|
April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease
Zobair M Younossi, Michael J Estep, Sean Felix, et al.
Hepatology (Baltimore, Md.)
|
December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity
Nasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
Plos One
|
September 3, 2010
Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1
Matthew A Schaller, Hannah Logue, Sumanta Mukherjee, et al.
Plos One
|
November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes
Nicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.
Respiratory Research
|
June 25, 2026
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trial
Helene Wallem Breisnes, Filipa Bica Simões, Peder Frederiksen, et al.
Frontiers in Immunology
|
July 23, 2021
The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome
Gwenny M Verstappen, Lu Gao, Sarah Pringle, et al.
Arthritis Research & Therapy
|
June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Hermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Arthritis Research & Therapy
|
August 31, 2024
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Hermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Annals of the Rheumatic Diseases
|
September 11, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
Peter C Taylor, Michael E Weinblatt, Iain B McInnes, et al.
Annals of the Rheumatic Diseases
|
September 12, 2023
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)
Roy M Fleischmann, Désirée van der Heijde, Vibeke Strand, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Clinical and Experimental Hepatology
|
April 21, 2025
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease
Zobair M Younossi, Michael J Estep, Sean Felix, et al.
Hepatology (Baltimore, Md.)
|
December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity
Nasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
Plos One
|
September 3, 2010
Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1
Matthew A Schaller, Hannah Logue, Sumanta Mukherjee, et al.
Plos One
|
November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes
Nicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.
Respiratory Research
|
June 25, 2026
Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trial
Helene Wallem Breisnes, Filipa Bica Simões, Peder Frederiksen, et al.
Frontiers in Immunology
|
July 23, 2021
The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome
Gwenny M Verstappen, Lu Gao, Sarah Pringle, et al.
Arthritis Research & Therapy
|
June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Hermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Arthritis Research & Therapy
|
August 31, 2024
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Hermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Annals of the Rheumatic Diseases
|
September 11, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
Peter C Taylor, Michael E Weinblatt, Iain B McInnes, et al.
Annals of the Rheumatic Diseases
|
September 12, 2023
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)
Roy M Fleischmann, Désirée van der Heijde, Vibeke Strand, et al.
Page
of 6